Analyst Reco. Exelon Corporation

Equities

EXC

US30161N1019

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
37.77 ^USD	+0.53%		+3.71%	+5.21%

Apr. 23	Morgan Stanley Adjusts Exelon's Price Target to $38 From $37, Keeps Equalweight Rating	MT
Apr. 22	Scotiabank Adjusts Exelon's Price Target to $37 From $39	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morgan Stanley Adjusts Exelon's Price Target to $38 From $37, Keeps Equalweight Rating	Apr. 23	MT
Scotiabank Adjusts Exelon's Price Target to $37 From $39	Apr. 22	MT
BMO Capital Adjusts Exelon Price Target to $40 From $39	Apr. 22	MT
Barclays Adjusts Price Target on Exelon to $39 From $36, Maintains Overweight Rating	Mar. 14	MT
Wells Fargo Cuts Price Target on Exelon to $39 From $41, Maintains Equalweight Rating	Feb. 22	MT
Exelon beats Q4 profit estimates on higher electricity rates	Feb. 21	RE
Stocks Decline Pre-Bell as Fed Outlook, Rates Weigh; Asia Mixed, Europe Mostly Up	Feb. 21	MT
Barclays Cuts Price Target on Exelon to $36 From $38, Maintains Overweight Rating	Jan. 22	MT
BofA Adjusts Price Target on Exelon to $36 From $38, Keeps Neutral Rating	Jan. 19	MT
In wait-and-see mode	Jan. 10
Mizuho Securities Upgrades Exelon to Buy From Neutral, Raises Price Target to $39 From $36	Jan. 10	MT
ANALYST RECOMMENDATIONS : Apple, Block, Palo Alto, Wise, Workday...	Jan. 10
Seaport Downgrades Exelon to Neutral From Buy	Jan. 08	MT
UBS Downgrades Exelon to Neutral From Buy, Adjusts Price Target to $37 From $47	Jan. 02	MT
RBC Cuts Price Target on Exelon to $38 From $45 Amid Illinois Grid Plan Rejection, Keeps Sector Perform Rating	Dec. 19	MT
Exelon 2025 EPS Forecast Lowered by Morgan Stanley Following Illinois Regulator's Rate Case Decision	Dec. 18	MT
Mizuho Adjusts Exelon's Price Target to $36 From $40, Keeps Neutral Rating	Dec. 18	MT
JPMorgan Downgrades Exelon to Neutral From Overweight, Cuts Price Target to $41 From $46	Dec. 18	MT
Morgan Stanley Downgrades Exelon to Equalweight From Overweight, Cuts Price Target to $38 From $45 Amid 'Unfavorable' Illinois Rate Case Decision	Dec. 18	MT
ANALYST RECOMMENDATIONS : Abbvie, Blackrock, Chubb, JPMorgan, Salesforce...	Dec. 18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Exelon Corporation

Equities

EXC

US30161N1019

Analyst Reco.

Filters